GeminIQ Website Logo

Viewing TKNO free

Subscribe for full history, 90+ metrics, screener, watchlist...

Alpha Teknova, Inc.

TKNO

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
6463334619222832
Short Term Investments
1113151921232726--0-
Accounts Receivable Net Current
565556455545
Income Taxes Receivable
----------00
Inventory Net
7777877811111211
Prepaid Expense And Other Assets Current
112211121122
Assets Current
313235373840434635394651
Property Plant And Equipment Net
394142434445464748495052
Operating Lease Right Of Use Asset
131414151515161717171617
Intangible Assets Net Excluding Goodwill
111212121313131314141417
Other Assets Noncurrent
111111122222
Assets
9699104108110114119124115121129138
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
121112111211
Accrued Liabilities Current
334434543465
Operating Lease Liability Current
222222222222
Long Term Debt Current
--0000431-0-
Liabilities Current
77876711107798
Deferred Income Tax Liabilities Net
111111111111
Other Accrued Liabilities Noncurrent
--0000000000
Long Term Debt
13131313131391112131313
Operating Lease Liability Noncurrent
121313141415151516161516
Liabilities
333435353435363736373939
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
206205205204203202201200184183182181
Retained Earnings Accumulated Deficit
-144-140-136-131-127-123-119-113-105-100-92-81
Stockholders Equity
6365697376798287798390100
Liabilities And Stockholders Equity
9699104108110114119124115121129138
Allowance For Doubtful Accounts Receivable Current
000000000000
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
490490490490490490490490490490490490
Common Stock Shares Issued
545454545453535341414141
Shares Outstanding
545454545453535341414141

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202635.00%43.75%24.25%---------
2025-17.10%-26.58%-25.57%2.13%43.50%34.28%-0.64%-14.23%-29.51%13.87%33.61%63.45%
20240.57%-31.03%113.79%15.62%23.93%77.83%4.33%21.93%12.29%-14.45%6.57%-1.97%
2023----36.01%-2.45%-30.07%46.06%76.35%64.53%-18.70%-27.24%-30.89%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.49
4.59
4.58
5.27
5.87
5.64
3.82
4.73
4.76
5.52
5.14
6.13
Quick Ratio
3.32
3.40
3.44
3.93
4.50
4.53
3.10
3.73
3.13
3.72
3.65
4.47
Working Capital
23.95M
24.78M
26.97M
29.63M
31.58M
32.69M
31.57M
36.21M
27.87M
31.78M
36.79M
42.74M
Leverage & Debt
Debt to Equity
0.53
0.52
0.51
0.48
0.45
0.45
0.44
0.42
0.46
0.45
0.43
0.39
Interest Coverage TTM
-18.14
-20.78
-23.91
-28.65
-36.98
-33.71
-38.06
-42.92
-23.68
-24.42
-26.05
-29.50
Debt Ratio
0.35
0.34
0.34
0.32
0.31
0.31
0.31
0.30
0.32
0.31
0.30
0.28
Efficiency & Turnover
Asset Turnover TTM
0.42
0.39
0.36
0.34
0.34
0.33
0.31
0.28
0.28
0.28
0.26
0.25
Days Sales Outstanding TTM
44.05
49.28
40.22
44.66
45.65
48.55
39.94
49.03
47.89
46.24
40.84
53.40
Receivables Turnover TTM
8.29
7.41
9.08
8.17
7.99
7.52
9.14
7.44
7.62
7.89
8.94
6.84
Per Share Metrics
Diluted EPS TTM
-0.31
-0.32
-0.32
-0.34
-0.40
-0.44
-0.57
-0.61
-0.84
-0.88
-1.16
-1.32
Free Cash Flow Per Share TTM
-0.15
-0.17
-0.18
-0.12
-0.12
-0.21
-0.29
-0.29
-0.45
-0.52
-0.84
-1.21
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
34.60%
34.01%
33.17%
30.97%
23.66%
20.99%
19.16%
17.71%
22.38%
27.36%
28.07%
30.16%
Operating Profit Margin TTM
-36.19%
-39.02%
-41.90%
-45.21%
-55.01%
-60.45%
-69.27%
-86.32%
-93.61%
-93.89%
-96.94%
-106.08%
Net Profit Margin TTM
-38.37%
-41.07%
-42.59%
-45.78%
-55.23%
-60.90%
-70.86%
-87.17%
-98.08%
-97.85%
-100.26%
-107.38%
Growth Metrics
Net Revenue Growth (1Y)
12.27%
9.29%
7.35%
9.50%
11.40%
3.79%
2.89%
-0.98%
-10.94%
-6.45%
-11.43%
-30.37%
Net Income Growth (1Y)
-22.00%
-26.29%
-35.47%
-42.49%
-37.27%
-35.40%
-27.28%
-19.63%
-33.76%
-29.00%
-22.52%
2.45%
EPS Growth (1Y)
-22.27%
-26.55%
-43.60%
-44.31%
-52.05%
-50.66%
-50.50%
-53.54%
-54.16%
-50.96%
-31.61%
-3.94%
Valuation Metrics
P/E TTM
-18.17
-9.02
-11.78
-18.18
-12.21
-11.90
-14.59
-7.92
-1.63
-3.00
-3.23
-2.12
P/B TTM
4.87
2.39
2.96
4.56
3.45
3.53
4.74
2.87
0.71
1.30
1.32
0.84
P/S TTM
6.97
3.71
5.02
8.32
6.74
7.25
10.34
6.90
1.60
2.93
3.24
2.28
Market Cap
304.65M
154.92M
203.24M
331.27M
262.43M
277.26M
390.33M
250.82M
55.97M
108.13M
118.69M
83.58M
Enterprise Value
311.86M
163.79M
210.45M
341.14M
272.19M
286.87M
396.06M
255.53M
49.64M
99.71M
103.45M
64.64M
Calculated Values
Free Cash Flow TTM
-8.27M
-9.07M
-9.79M
-6.18M
-6.20M
-11.16M
-13.52M
-15.22M
-18.18M
-21.42M
-26.75M
-36.30M
Net Debt
7.21M
8.86M
7.21M
9.87M
9.76M
9.61M
5.74M
4.71M
-6.33M
-8.42M
-15.23M
-18.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-03-06Purchase
Owner: Lowell, Matthew
Title: Chief Financial Officer
Shares: 40,000
Price/Share: $2.19
Value: $87,600.00
Shares Owned: 168,376
Relationship: Officer
Ownership: Direct
2026-03-06Purchase
Owner: Gunstream, Stephen
Title: President and CEO
Shares: 26,000
Price/Share: $2.15
Value: $55,900.00
Shares Owned: 269,497
Relationship: Director,Officer
Ownership: Direct
2025-06-27Sale
Owner: Demski, Martha J
Title: -
Shares: 8,000
Price/Share: $5.06
Value: $40,480.00
Shares Owned: 12,000
Relationship: Director
Ownership: Direct
2024-07-12Purchase
Owner: Telegraph, Hill Partners …
Title: -
Shares: 12,096,773
Price/Share: $1.24
Value: $14,999,998.52
Shares Owned: 11,126,929
Relationship: TenPercentOwner
Ownership: Indirect
2024-07-12Purchase
Owner: Lowell, Matthew
Title: Chief Financial Officer
Shares: 40,322
Price/Share: $1.24
Value: $49,999.28
Shares Owned: 128,376
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
14.22%
Inst. Shares: 7,625,245
Shares Outstanding: 53,606,278
2025-12-31
13.08%
Inst. Shares: 6,996,800
Shares Outstanding: 53,483,075
2025-09-30
13.85%
Inst. Shares: 7,413,307
Shares Outstanding: 53,516,986
2025-06-30
14.11%
Inst. Shares: 7,542,908
Shares Outstanding: 53,448,736
2025-03-31
11.10%
Inst. Shares: 5,928,257
Shares Outstanding: 53,421,533

Alpha Teknova, Inc. (TKNO) — SEC Financial Statements & Analysis

Alpha Teknova, Inc. (TKNO) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Alpha Teknova, Inc. trades on Nasdaq as: TKNO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Alpha Teknova, Inc. reported a 12.27% year-over-year revenue growth, a Gross Profit Margin of 34.60% (TTM), a Debt-to-Equity ratio of 0.53x, a Price-to-Sales (P/S) ratio of 6.97x (TTM), a Price-to-Book (P/B) ratio of 4.87x (TTM), at a market cap of $304.65M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
12.27%
Gross Profit Margin TTM
34.60%
Debt To Equity
0.53x
P/S TTM
6.97x
P/B TTM
4.87x
Market Cap
$304.65M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Alpha Teknova, Inc. in?

Alpha Teknova, Inc. (TKNO) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is TKNO's market cap?

Alpha Teknova, Inc. (TKNO) has a market capitalization of $304.65M as of 2026-06-30.

What exchange does TKNO trade on?

Alpha Teknova, Inc. (TKNO) trades on the Nasdaq.

Where is Alpha Teknova, Inc. incorporated?

Alpha Teknova, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.